Literature DB >> 19940288

When to consider the use of antibiotics in the treatment of 2009 H1N1 influenza-associated pneumonia.

Peter F Wright1, Kathryn B Kirkland, John F Modlin.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2009        PMID： 19940288     DOI： 10.1056/NEJMopv0910749

Source DB:  PubMed          Journal:  N Engl J Med        ISSN： 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  10 in total

1.  Chinese guidelines for diagnosis and treatment of influenza (2011).

Authors:  Nan-Shan Zhong; Yi-Min Li; Zi-Feng Yang; Chen Wang; You-Ning Liu; Xing-Wang Li; Yue-Long Shu; Guang-Fa Wang; Zhan-Cheng Gao; Guo-Hua Deng; Li-Xian He; Xiu-Ming Xi; Bin Cao; Kun-Ling Shen; Hao Wu; Ping-An Zhou; Qing-Quan Li
Journal:  J Thorac Dis       Date:  2011-12       Impact factor: 2.895

Review 2.  Influenza-related pneumonia.

Authors:  Mark H Almond; Danny F McAuley; Matt P Wise; Mark J D Griffiths
Journal:  Clin Med (Lond)       Date:  2012-02       Impact factor: 2.659

3.  Recent advances in the diagnosis and treatment of influenza pneumonia.

Authors:  Lucia Marzoratti; Hernán A Iannella; Victoria Fernández Gómez; Sandra B Figueroa
Journal:  Curr Infect Dis Rep       Date:  2012-06       Impact factor: 3.725

4.  Early recognition of the 2009 pandemic influenza A (H1N1) pneumonia by chest ultrasound.

Authors:  Americo Testa; Gino Soldati; Roberto Copetti; Rosangela Giannuzzi; Grazia Portale; Nicolò Gentiloni-Silveri
Journal:  Crit Care       Date:  2012-02-17       Impact factor: 9.097

5.  Role of procalcitonin and C-reactive protein in differentiation of mixed bacterial infection from 2009 H1N1 viral pneumonia.

Authors:  Shin Ahn; Won Young Kim; Sung-Han Kim; SangBum Hong; Chae-Man Lim; YounSuck Koh; Kyung Soo Lim; Won Kim
Journal:  Influenza Other Respir Viruses       Date:  2011-03-30       Impact factor: 4.380

Review 6.  Blocking IL-1 to prevent respiratory failure in COVID-19.

Authors:  Frank L van de Veerdonk; Mihai G Netea
Journal:  Crit Care       Date:  2020-07-18       Impact factor: 9.097

7.  Clinical characteristics and outcomes in hospitalized patients with respiratory viral co-infection during the 2009 H1N1 influenza pandemic.

Authors:  Ignacio A Echenique; Philip A Chan; Kimberle C Chapin; Sarah B Andrea; Joseph L Fava; Leonard A Mermel
Journal:  PLoS One       Date:  2013-04-09       Impact factor: 3.240

8.  Severe influenza treatment guideline.

Authors:  Won Suk Choi; Ji Hyeon Baek; Yu Bin Seo; Sae Yoon Kee; Hye Won Jeong; Hee Young Lee; Byung Wook Eun; Eun Ju Choo; Jacob Lee; Young Keun Kim; Joon Young Song; Seong-Heon Wie; Jin Soo Lee; Hee Jin Cheong; Woo Joo Kim
Journal:  Korean J Intern Med       Date:  2014-01-02       Impact factor: 2.884

9.  Factors Affecting the Incidence of Hospitalized Pneumonia after Influenza Infection in Korea Using the National Health Insurance Research Database, 2014-2018: Focusing on the Effect of Antiviral Therapy in the 2017 Flu Season.

Authors:  Kyeong Hyang Byeon; Jaiyong Kim; Bo Youl Choi; Jin Yong Kim; Nakyoung Lee
Journal:  J Korean Med Sci       Date:  2020-09-28       Impact factor: 2.153

Review 10.  Role of Chest Imaging in Viral Lung Diseases.

Authors:  Diletta Cozzi; Eleonora Bicci; Alessandra Bindi; Edoardo Cavigli; Ginevra Danti; Michele Galluzzo; Vincenza Granata; Silvia Pradella; Margherita Trinci; Vittorio Miele
Journal:  Int J Environ Res Public Health       Date:  2021-06-14       Impact factor: 3.390
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.